Cleared Traditional

K222125 - Arm Blood Pressure Monitor

K222125 is an FDA 510(k) clearance for Arm Blood Pressure Monitor, manufactured by Shenzhen AOJ Medical Technology Co., Ltd.. The device is a Class 2 Cardiovascular device with product code DXN cleared through the Traditional 510(k) pathway after a 136-day FDA review.

K222125 · Shenzhen AOJ Medical Technology Co., Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2022
Decision
136d
Days
Class 2
Risk

K222125 is an FDA 510(k) clearance for the Arm Blood Pressure Monitor, models AOJ-30A, AOJ-30B, AOJ-30C, AOJ-30D, AOJ-30.... Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Shenzhen AOJ Medical Technology Co., Ltd. (Shenzhen, CN). The FDA issued a Cleared decision on December 1, 2022 after a review of 136 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Shenzhen AOJ Medical Technology Co., Ltd. devices

FDA 510(k) Submission Details - K222125

510(k) Number K222125 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 18, 2022
Decision Date December 01, 2022
Days to Decision 136 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
11d slower than avg
Panel avg: 125d · This submission: 136d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXN Device Classification - Class 2, Special Controls

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 565
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K222125.
Electronic Sphygmomanometers
K222394 · Qingdao Yasee Medical Device Co., Ltd. · Mar 2023
Arm Blood Pressure Monitor
K222869 · Andon Health Co, Ltd. · Feb 2023
Microlife Upper Arm Automatic Digital BPM, Model WatchBP Office Vascular (TWIN200 VSR)
K222153 · Microlife Intellectual Property GmbH · Feb 2023
GUS610 Blood pressure monitor
K222160 · Globalcare Medical Technology Co., Ltd. · Nov 2022
HemoSphere Advanced Monitor, HemoSphere ClearSight Module
K221833 · Edwards Lifesciences, LLC · Nov 2022
YUWELL Electronic Blood Pressure Monitor
K221372 · Jiangsu Yuyue Medical Equipment& Supply Co., Ltd. · Oct 2022